📊 NTRBW Key Takeaways
Is NutriBand Inc. (NTRBW) a Good Investment?
NutriBand Inc. is a fundamentally distressed company burning cash at an unsustainable rate with minimal revenue generation. Despite holding $5.3M in cash, operating losses of $7.3M per period combined with negative operating cash flow of $4.4M indicate the company is rapidly consuming its liquidity cushion with no clear path to profitability.
Fundamentals show a tiny, flat revenue base, sub-30% gross margin, and extremely negative operating and net margins driving heavy cash burn and deeply negative ROE/ROA. While the balance sheet is clean with strong liquidity, ample cash, and negligible debt, current operating cash outflows imply a limited runway without rapid revenue scaling or margin improvement. Absent clear progress on commercialization and cost discipline, dilution and continued losses are likely.
NutriBand Inc. Key Strengths (NTRBW)
- Strong liquidity position with $5.3M cash representing 63% of total assets
- Minimal debt burden with only $1.8K long-term debt and 0.00x debt-to-equity ratio
- Low current liabilities relative to liquid assets providing short-term solvency
- Net cash position with minimal liabilities and no leverage
- Strong liquidity (current 7.5x, quick 7.35x) supports near‑term obligations
- Low capex needs indicate an asset‑light model
NTRBW Stock Risks: NutriBand Inc. Investment Risks
- Severe operating losses of $7.3M against $1.6M revenue, indicating fundamental business model failure
- Negative operating cash flow of $4.4M per period means company will deplete cash reserves in approximately 1.2 periods at current burn rate
- Revenue stagnation with 0.0% YoY growth while operating expenses remain massive, showing no operational leverage or path to scaling
- Negative ROE of -96.2% and ROA of -86.3% demonstrate value destruction across all invested capital
- Operating margin of -446% and net margin of -443.9% indicate the company loses $4.46 for every dollar of revenue
- Persistent operating losses and negative FCF (-$4.41M) with -446% operating margin
- Flat revenue and weak gross margin (29.2%) suggest limited operating leverage
- Potential equity dilution to fund operations as cash runway compresses
Key Metrics to Watch
- Quarterly cash position and runway remaining at current burn rate
- Revenue trends and new product launch success in orthopedic appliances sector
- Operating expense reduction initiatives and path to operating cash flow positivity
- Quarterly revenue growth and gross margin trajectory
- Operating cash burn versus cash balance (runway)
NutriBand Inc. (NTRBW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 7.53x current ratio provides a solid financial cushion.
NTRBW Profit Margin, ROE & Profitability Analysis
NTRBW vs Healthcare Sector: How NutriBand Inc. Compares
How NutriBand Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is NutriBand Inc. Stock Overvalued? NTRBW Valuation Analysis 2026
Based on fundamental analysis, NutriBand Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
NutriBand Inc. Balance Sheet: NTRBW Debt, Cash & Liquidity
NTRBW Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: NutriBand Inc.'s revenue has grown significantly by 81% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.99 indicates the company is currently unprofitable.
NTRBW Revenue Growth, EPS Growth & YoY Performance
NTRBW Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $346.1K | -$1.4M | $-0.12 |
| Q2 2026 | $442.8K | -$1.7M | $-0.15 |
| Q1 2026 | $408.5K | -$1.4M | $-0.12 |
| Q3 2025 | $427.8K | -$1.4M | $-0.12 |
| Q1 2025 | $408.5K | -$1.0M | $-0.13 |
| Q3 2024 | $427.8K | -$1.1M | $-0.14 |
| Q2 2024 | $442.8K | -$829.2K | $-0.11 |
| Q2 2023 | $456.1K | -$829.2K | $-0.11 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
NutriBand Inc. Dividends, Buybacks & Capital Allocation
NTRBW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for NutriBand Inc. (CIK: 0001676047)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NTRBW
What is the AI rating for NTRBW?
NutriBand Inc. (NTRBW) has a Combined AI Grade of C from Claude (D) and ChatGPT (C) with 84% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are NTRBW's key strengths?
Claude: Strong liquidity position with $5.3M cash representing 63% of total assets. Minimal debt burden with only $1.8K long-term debt and 0.00x debt-to-equity ratio. ChatGPT: Net cash position with minimal liabilities and no leverage. Strong liquidity (current 7.5x, quick 7.35x) supports near‑term obligations.
What are the risks of investing in NTRBW?
Claude: Severe operating losses of $7.3M against $1.6M revenue, indicating fundamental business model failure. Negative operating cash flow of $4.4M per period means company will deplete cash reserves in approximately 1.2 periods at current burn rate. ChatGPT: Persistent operating losses and negative FCF (-$4.41M) with -446% operating margin. Flat revenue and weak gross margin (29.2%) suggest limited operating leverage.
What is NTRBW's revenue and growth?
NutriBand Inc. reported revenue of $1.6M.
Does NTRBW pay dividends?
NutriBand Inc. does not currently pay dividends.
Where can I find NTRBW SEC filings?
Official SEC filings for NutriBand Inc. (CIK: 0001676047) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NTRBW's EPS?
NutriBand Inc. has a diluted EPS of $-2.54.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is NTRBW's fundamental grade?
Based on our AI fundamental analysis in June 2026, NutriBand Inc. has a C grade with 84% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is NTRBW stock overvalued or undervalued?
Valuation metrics for NTRBW: ROE of -96.2% (sector avg: 15%), net margin of -443.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is NTRBW's AI grade for 2026?
Our dual AI analysis gives NutriBand Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NTRBW's free cash flow?
NutriBand Inc.'s operating cash flow is $-4.4M, with capital expenditures of $5.3K. FCF margin is -269.5%.
How does NTRBW compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -443.9% (avg: 12%), ROE -96.2% (avg: 15%), current ratio 7.53 (avg: 2).